-
May 17, 2022, 15:36
by
Many emerging PROTAC-based technologies such as RNA-PROTACs and Photoswitchable PROTACs have expanded the scope of PROTAC development, providing more feasible potential strategies for the clinical treatment of related diseases.
Full story
-
May 17, 2022, 15:36
by
Stable isotope labeling is a powerful technique with promising applications.
Full story
-
May 17, 2022, 15:36
by
ADC Technology releases a wide range of one-stop services related to ADC development such as antibody selection/modification, ADC payload and linker development, ADC conjugation, and ADC characterization and preclinical evaluation to help partners win the race of ADC research.
Full story
-
May 17, 2022, 15:36
by
Elligo Health Research and Peoples Rx Partner on Initiative to Help Share More Clinical Research Opportunities
Full story
-
May 17, 2022, 15:36
by
ENPICOM has announced that Genovac will use its IGX Platform for its antibody discovery workflows.
Full story
-
May 17, 2022, 15:36
by
Scipio bioscience has announced that Asteria©, the latest breakthrough single-cell RNA-sequencing kit, is now commercially available for any researcher worldwide.
Full story
-
May 17, 2022, 15:36
by
Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the clinical and commercial production of cell and gene therapies, today announced the opening of its new 45,000-square-foot facility dedicated to the production of viral vectors and cell-based products used in cell and gene therapies, vaccines, oncolytic therapies and other genetic medicines.
Full story
-
May 17, 2022, 15:36
by
CYTENA has entered a collaboration agreement with ExcellGene SA, a leading biologics CDMO that manufactures recombinant proteins.
Full story
-
May 17, 2022, 15:36
by
Biotium is announcing the acquisition of Cell Data Sciences RNAstorm™ and DNAstorm™ kits for RNA/DNA extraction.
Full story
-
May 17, 2022, 15:36
by
RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT)* for all stages of cancer, today announced the enrollment of the first patient into its PREMIER registry, a prospective, real-world evidence clinical outcomes registry for patients with all stages of cancer, at the University of Texas (UT) Southwestern in Dallas.
Full story
-
May 17, 2022, 15:36
by
Full story
-
May 17, 2022, 15:36
by
Full story
-
May 17, 2022, 15:36
by
Full story
-
May 17, 2022, 15:36
by
Full story
-
May 17, 2022, 15:36
by
Full story
-
May 17, 2022, 15:36
by
Full story
-
May 17, 2022, 15:33
by
I have been searching about lately. The type of details here on the forum is excellent and helpful and is going to assist my friends and I in our studies a couple times a week. It seems like all of the members here acquired a significant amount of info about this and other subjects and types of info like wise show it. I am not browsing websites most of the time although when I get an opportunity i'm usually avidly searching for this type of knowledge and things closely related to it. When anyone gets a chance, take a look at my website: [url=https://elpasodisabilitylawyer.com/practice-areas/]ssa attorney in san elizario, tx[/url]
Full story
-
May 17, 2022, 15:33
by
Packaging is another factor that decides the stability and integrity of drugs. Except for the role as an excipient producer and supplier, the US-based CRO company CD Formulation today announces that it newly launches a wide range of pharmaceutical packaging services, providing support throughout the whole process of packaging design, from material selection to chemical and surface analysis and to design selection.
Full story
-
May 17, 2022, 15:33
by
With broad use in the manufacture of cleaning, pharmaceutical, cosmetic, and food products, the significance of polymer surfactants can never be neglected. In a recent statement, Alfa Chemistry announced the supply of a wide range of polymer surfactants for potential uses in both scientific research and industrial manufacturing.
Full story
-
May 17, 2022, 15:33
by
Continuing to be a trust-worthy CRO company for drug formulation and development, CD Formulation recently announces the enrichment of its active pharmaceutical ingredient excipient offerings. Now a number of API excipients are readily obtainable at CD Formulation, including Cetrorelix Acetate, Fondaparinux Sodium, Calcitriol, Vitamine D3, Tirofiban Hydrochloride, Eptifibatide, Ferric Ammonium Citrate, Calcipotriol API, Calcium Orotate, Meglumine, Obeticholic Acid, Potassium Magnesium Citrate and Magnesium Oxide.
Full story